Skip to main content
Journal cover image

Responses of mental stress-induced myocardial ischemia to escitalopram treatment: background, design, and method for the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment trial.

Publication ,  Journal Article
Jiang, W; Velazquez, EJ; Samad, Z; Kuchibhatla, M; Martsberger, C; Rogers, J; Williams, R; Kuhn, C; Ortel, TL; Becker, RC; Pristera, N ...
Published in: Am Heart J
January 2012

BACKGROUND: Mental stress-induced myocardial ischemia (MSIMI) is common in patients with clinically stable coronary heart disease (CHD) and is associated with poor outcomes. Depression is a risk factor of MSIMI. The REMIT trial investigates whether selective serotonin reuptake inhibitor (SSRI) treatment can improve MSIMI. The rationale and outline of the study are described. METHOD: In this single-center randomized clinical trial, adult patients with clinically stable CHD are recruited for baseline mental and exercise stress testing assessed by echocardiography. In addition, psychometric questionnaires are administered, and blood samples are collected for platelet activity analysis. Patients who demonstrate MSIMI, defined by new abnormal wall motion, ejection fraction reduction ≥8%, and/or development of ischemic ST change in electrocardiogram during mental stress testing, are randomized at a 1:1 ratio to escitalopram or placebo for 6 weeks. Approximately 120 patients with MSIMI are enrolled in the trial. The stress testing, platelet activity assessment, and psychometric questionnaires are repeated at the end of the 6-week intervention. The hypothesis of the study is that SSRI treatment improves MSIMI via mood regulation and modification of platelet activity. CONCLUSION: The REMIT study examines the effect of SSRI on MSIMI in vulnerable patients with CHD and probes some potential underlying mechanisms.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

January 2012

Volume

163

Issue

1

Start / End Page

20 / 26

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Stress, Psychological
  • Selective Serotonin Reuptake Inhibitors
  • Research Design
  • Psychometrics
  • Myocardial Infarction
  • Humans
  • Exercise Test
  • Depressive Disorder
  • Citalopram
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jiang, W., Velazquez, E. J., Samad, Z., Kuchibhatla, M., Martsberger, C., Rogers, J., … O’Connor, C. M. (2012). Responses of mental stress-induced myocardial ischemia to escitalopram treatment: background, design, and method for the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment trial. Am Heart J, 163(1), 20–26. https://doi.org/10.1016/j.ahj.2011.09.018
Jiang, Wei, Eric J. Velazquez, Zainab Samad, Maragatha Kuchibhatla, Carolyn Martsberger, Joseph Rogers, Redford Williams, et al. “Responses of mental stress-induced myocardial ischemia to escitalopram treatment: background, design, and method for the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment trial.Am Heart J 163, no. 1 (January 2012): 20–26. https://doi.org/10.1016/j.ahj.2011.09.018.
Jiang W, Velazquez EJ, Samad Z, Kuchibhatla M, Martsberger C, Rogers J, Williams R, Kuhn C, Ortel TL, Becker RC, Pristera N, Krishnan R, O’Connor CM. Responses of mental stress-induced myocardial ischemia to escitalopram treatment: background, design, and method for the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment trial. Am Heart J. 2012 Jan;163(1):20–26.
Journal cover image

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

January 2012

Volume

163

Issue

1

Start / End Page

20 / 26

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Stress, Psychological
  • Selective Serotonin Reuptake Inhibitors
  • Research Design
  • Psychometrics
  • Myocardial Infarction
  • Humans
  • Exercise Test
  • Depressive Disorder
  • Citalopram